Boehler Adam - 11 Jun 2024 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 Jun 2024, 16:05:22 UTC
Prior SEC filing
31 May 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Anita Beth Adams, as attorney-in-fact

Key filing fact

Boehler Adam filed Form 4 for Privia Health Group, Inc. (PRVA) on 13 Jun 2024.

Key facts

  • This page summarizes Boehler Adam's Form 4 filing for Privia Health Group, Inc. (PRVA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Jun 2024, 16:05.

Change

  • Previous filing in this sequence was filed on 31 May 2024.
  • Current net transaction value: +$6,006.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRVA transaction

Common Stock, $0.01 par value per share

Purchase

Transaction value
$6,006
Shares
+364
Change %
+0.01%
Price
$16.50
Shares after
5,773,522
Date
11 Jun 2024
Ownership
See footnote
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares held or acquired by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP, of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .